Abstract
Secure the Future, Bristol-Myers Squibb's landmark $115 million program to offer care and support for the women and children affected and infected by HIV/AIDS in 9 countries in Southern and Western Africa, recently marked its 5-year anniversary. During that time it has supported nearly 200 programs in these countries to offer new approaches to medical research and care and community outreach and education, especially in resource-limited settings. These projects have included new studies focusing on mother-to-child transmission of HIV after birth, the development of CD4 tests that have reduced costs by up to 80%, the first HIV reference laboratory for HIV diagnosis and testing in Botswana, the first pediatric HIV/AIDS treatment and research center in Africa, and a groundbreaking healthcare training curriculum in HIV/AIDS, along with scores of projects supporting home-based care, counseling, prevention, destigmatization and education, income generation, nutritional support, and much more. In each project, the aim has been to find ways to create sustainable solutions that are appropriate for each setting and to do so in ways that build capacity for the future in each of these areas. Secure the Future recently opened a series of comprehensive community-based treatment and support centers to serve as model programs through which newly available antiretroviral treatments can be delivered, while at the same time offering the kind of community-based support and resources, from counseling to home-based care, that will be required if these treatments are to truly succeed. (Published: 8 July 2004) doi:10.1186/1758-2652-6-3-57 Full text: BioMed Central: http://www.biomedcentral.com/1758-2652/content/6/3/57 PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738663/
Highlights
Secure the Future, Bristol-Myers Squibb's landmark $115 million program to offer care and support for the women and children affected and infected by HIV/AIDS in 9 countries in Southern and Western Africa, recently marked its 5-year anniversary. During that time it has supported nearly 200 programs in these countries to offer new approaches to medical research and care and community outreach and education, especially in resourcelimited settings. These projects have included new studies focusing on mother-to-child transmission of HIV after birth, the development of CD4 tests that have reduced costs by up to 80%, the first HIV reference laboratory for HIV diagnosis and testing in Botswana, the first pediatric HIV/AIDS treatment and research center in Africa, and a groundbreaking healthcare training curriculum in HIV/ AIDS, along with scores of projects supporting homebased care, counseling, prevention, destigmatization and education, income generation, nutritional support, and much more
In founding eJIAS, the International AIDS Society has recognized that the HIV/AIDS crisis in Africa and around the world demands new approaches to how scientific information is disseminated
The urgency is great, and the needs are even greater, as the ability of a growing number of researchers and clinicians to publish without assistance, according to the rules and requirements of most established medical journals, is often as limited as their ability to study and respond to the AIDS pandemic in the resource-restricted settings in which they work
Summary
Secure the Future, Bristol-Myers Squibb's landmark $115 million program to offer care and support for the women and children affected and infected by HIV/AIDS in 9 countries in Southern and Western Africa, recently marked its 5-year anniversary. Open Access eJIAS and the Bristol-Myers Squibb Foundation's Secure the Future
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
